Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 10, 2009

Premium

Agendia has tapped Al Luderer to serve on its supervisory board. Luderer is CEO of BioTrove, and he is on the scientific advisory board at Washington University's Department of Biomedical Engineering. He formerly was CEO of Light Sciences Corporation, and he has been chief operating officer at BioMerieux. He also previously served as vice president of technology development and support at Boehringer Mannheim.


Enzo Biochem has appointed Kevin Krenitsky as president of its Enzo Clinical Labs subsidiary.

Prior to joining Enzo Clinical Labs, Krenitsky was CEO of Bioserve Biotechnologies. Previous to Bioserve, he was CEO of Parkway Clinical Laboratories. He also served as senior vice president and division head at SeraCare Life Sciences’ Genomics Collaborative Division.

Krenitsky holds an MD from Jefferson Medical College.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.